Quantcast

Latest Brain tumor Stories

2014-10-22 23:06:03

Six new members elected at ABTA annual meeting Chicago, IL (PRWEB) October 22, 2014 The American Brain Tumor Association (ABTA) – the first and now only organization to fund brain tumor research and provide education and information on all tumor types for all ages – has elected six new members to its Board of Directors as well as the full slate of officers at its recent annual meeting in Chicago. “It is a privilege to welcome new members to the ABTA’s Board of Directors who...

2014-10-21 12:32:26

Cancer Survivor Shares Personal Story During National Breast Cancer Awareness Month RENO, Nev., Oct. 21, 2014 /PRNewswire/ -- As the second-most diagnosed cancer in women in the U.S., breast cancer impacts the lives of many. Debbie Black, a Nevada resident, is among those whose life has been dramatically impacted by the disease. http://photos.prnewswire.com/prnvar/20141020/153187 Initially diagnosed with stage II breast cancer at the age of 30, Black underwent aggressive...

2014-10-20 23:02:05

In-demand research report “Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM” elaborated by GBI Research is now available at MarketPublishers.com. According to the study, the APAC glioblastoma multiforme therapeutics market is predicted to reach USD 105.8 million by 2020. London, UK (PRWEB) October 20, 2014 The glioblastoma multiforme (GBM) therapeutics market in the APAC...

2014-10-17 23:08:13

NuvOx Pharma, a biotechnology company based in Tucson, Arizona, has received a $1Million grant from the National Cancer Institute (NCI) “Nanoparticle-based Sensitizer for Radiation Therapy of Glioblastoma, (NCI Phase II SBIR, R44CA144817 - 02A1)". Tucson, AZ (PRWEB) October 17, 2014 NuvOx Pharma, a biotechnology company based in Tucson, Arizona, has received a $1Million grant from the National Cancer Institute (NCI) “Nanoparticle-based Sensitizer for Radiation Therapy of...

2014-10-16 23:14:21

National Patient Advocacy Organization Revs Up Its Sumer Brain Tumor Education & Awareness Campaign Seattle WA (PRWEB) October 16, 2014 Leveraging the momentum created by its annual May Education, Awareness & Celebration Luncheon, the Chris Elliott Fund stepped up its Brain Tumor Education and Awareness campaign for the summer of 2014. June and July’s education and outreach campaigns were centered around the 13th Annual Educational & Celebrity Golf Tournament, an event...

2014-10-16 23:13:11

This state-of-the-art system will enable us to offer cancer patients a fast, effective surgical option without an incision or the need to recover in a hospital setting. South Miami, FL (PRWEB) October 16, 2014 Innovative Cancer Institute announced it is the first in the Southeastern United States to install the Edge™ system from Varian Medical Systems, for treating cancer and other conditions with high-precision, non-invasive radiosurgery. “This state-of-the-art system will enable us...

2014-10-14 08:34:17

First Patient Has Begun Treatment Process; Additional Patients Being Assessed; Waiting List Established BETHESDA, Md., Oct. 14, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that the DCVax-L Hospital Exemption Program that was approved by the German regulatory authority earlier this year is now under way. The first patient with Glioblastoma...

2014-10-14 04:22:05

TUBINGEN, Germany, October 14, 2014 /PRNewswire/ -- Regulatory authority approves clinical trial for Glioma Actively Personalized Vaccine Consortium (GAPVAC) First centers to enroll glioblastoma patients opened in Heidelberg and Tuebingen European Union supports the initiative with a EUR6 million grant immatics biotechnologies GmbH and BioNTech AG announce...

2014-10-13 12:25:28

ASHEVILLE, N.C., Oct. 13, 2014 /PRNewswire-USNewswire/ -- The Pediatric Brain Tumor Foundation's Starry Night 8.5K is an evening walk/run to help kids battling one of the deadliest forms of childhood cancer. Starry Night Houston is coming to Discovery Green on Saturday, Nov. 15. More than 28,000 children in the United States are living with a brain tumor. Each of Starry Night's 28,000 steps will shine light on their illness and raise funds for lifesaving medical research and...

2014-10-09 08:26:38

LOS ANGELES, Oct. 9, 2014 /PRNewswire/ -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced the initiation of enrollment in an open-label Phase 1b clinical trial designed to investigate the preliminary safety and activity of aldoxorubicin plus gemcitabine in subjects with metastatic solid tumors. Aldoxorubicin is CytRx's modified version of the widely-used chemotherapeutic agent, doxorubicin. The Phase 1b...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.